These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10933336)

  • 1. Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples.
    Carpenter MJ; Chutuape MA; Stitzer ML
    Drug Alcohol Depend; 1998 Dec; 53(1):11-5. PubMed ID: 10933336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing intravenous cocaine use in opiate users treated with prescribed heroin.
    Blättler R; Dobler-Mikola A; Steffen T; Uchtenhagen A
    Soz Praventivmed; 2002; 47(1):24-32. PubMed ID: 12050926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
    Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome.
    Smolka M; Schmidt LG
    Addiction; 1999 Aug; 94(8):1191-8. PubMed ID: 10615734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking heroin with cannabis versus injecting heroin: unexpected impact on treatment outcomes.
    Morgan N; Daniels W; Subramaney U
    Harm Reduct J; 2019 Dec; 16(1):65. PubMed ID: 31805971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment.
    Man LH; Best D; Gossop M; Stillwell G; Strang J
    Eur Addict Res; 2004; 10(1):35-40. PubMed ID: 14665804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What happens when contingency management treatment ends? A tale of two clients.
    Petry NM; Kelley L; Brennan M; Sierra S
    Am J Addict; 2008; 17(3):241-4. PubMed ID: 18464002
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of heroin chasers with heroin injectors in Switzerland.
    Stohler R; Dürsteler-Mac Farland KM; Gramespacher C; Petitjean S; Battegay R; Ladewig D
    Eur Addict Res; 2000 Sep; 6(3):154-9. PubMed ID: 11060480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment.
    Dobler-Mikola A; Hättenschwiler J; Meili D; Beck T; Böni E; Modestin J
    J Subst Abuse Treat; 2005 Dec; 29(4):259-65. PubMed ID: 16311178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.
    Gossop M; Stewart D; Marsden J; Kidd T; Strang J
    Addict Behav; 2004 Aug; 29(6):1085-94. PubMed ID: 15236809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chief health risks associated with intravenous heroin and cocaine abuse].
    Ben Diane MK; Feroni I; Poncet M; Obadia Y
    Presse Med; 2000 Mar; 29(8):453-7. PubMed ID: 10738515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploration of alcohol use severity and route of drug administration among persons that use heroin and cocaine.
    Scherer M; Harrell PT; Trenz RC; Canham S; Latimer WW
    Subst Abus; 2016; 37(2):343-8. PubMed ID: 26566678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Out of addictions: Alcohol, or alcohol to alcohol].
    Simmat-Durand L; Vellut N; Lejeune C; Jauffret-Roustide M; Mougel S; Michel L; Planche M
    Encephale; 2017 Aug; 43(4):326-333. PubMed ID: 27372354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an 18-month, NHS-based, treatment exposure for heroin dependence: results from the London Area Treat 2000 Study.
    Schifano F; Martinotti G; Cunniff A; Reissner V; Scherbaum N; Ghodse H
    Am J Addict; 2012; 21(3):268-73. PubMed ID: 22494230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of dissociation in detoxified substance abusers and their relationship to chronicity of alcohol and drug use.
    Wenzel K; Bernstein DP; Handelsman L; Rinaldi P; Ruggiero J; Higgins B
    J Nerv Ment Dis; 1996 Apr; 184(4):220-7. PubMed ID: 8604031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples.
    Strang J; Griffiths P; Powis B; Abbey J; Gossop M
    Drug Alcohol Depend; 1997 Jun; 46(1-2):115-8. PubMed ID: 9246559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.